Testing effectiveness (Phase 2)Study completedNCT00002829What this trial is testingBone Marrow Transplantation in Treating Patients With LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00880581What this trial is testingIntratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell LymphomasWho this might be right forLymphoma, Non-HodgkinLymphomaLymphomas: Non-Hodgkin Follicular / Indolent B-Cell+1 more Ronald Levy 30
Early research (Phase 1)Ended earlyNCT00880867What this trial is testingIntratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell LymphomaWho this might be right forB Cell LymphomaT Cell Lymphoma Nevada Cancer Institute 3
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00784927What this trial is testingLenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin LymphomaWho this might be right forLymphoma Mayo Clinic 36
Early research (Phase 1)Study completedNCT03410901What this trial is testingTLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin LymphomasWho this might be right forB-Cell Non-Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+5 more Ronald Levy 14
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Not applicableEnded earlyNCT00513318What this trial is testingPilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesWho this might be right forAcute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more University of California, San Francisco 15
Testing effectiveness (Phase 2)Study completedNCT00220285What this trial is testingStudy for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's LymphomaLymphoma, B-CellLymphoma, Low-Grade Bayer 45
Early research (Phase 1)Study completedNCT00301951What this trial is testingLow-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT02332980What this trial is testingPembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+20 more Mayo Clinic 65
Testing effectiveness (Phase 2)Study completedNCT01718691What this trial is testingEfficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell LymphomaWho this might be right forLow-grade B Cell Non-Hodgkin's LymphomaMantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated SymBio Pharmaceuticals 70
Testing effectiveness (Phase 2)Ended earlyNCT02266147What this trial is testingStudy of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell LymphomaWho this might be right forB-cell Lymphoma Dynavax Technologies Corporation 29
Testing effectiveness (Phase 2)Study completedNCT00066248What this trial is testingCyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentWho this might be right forBrain TumorCentral Nervous System TumorsCachexia+5 more University of South Florida 70
Testing effectiveness (Phase 2)WithdrawnNCT01263418What this trial is testingOfatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell LymphomasWho this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, B-Cell, Marginal Zone+2 more UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00496873What this trial is testingEvaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanWho this might be right forLymphoma M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)UnknownNCT00377195What this trial is testingInvolved Field Radiotherapy for Non-gastric Marginal Zone LymphomaWho this might be right forNon-gastric Marginal Zone Lymphoma Trans Tasman Radiation Oncology Group 79
Testing effectiveness (Phase 2)WithdrawnNCT01138579What this trial is testingStudy of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell TransplantationWho this might be right forLeukemiaStem Cell Transplantation Technical University of Munich